Jim R Wright

Summary

Affiliation: McMaster University
Country: Canada

Publications

  1. pmc Almost famous: E. Clark Noble, the common thread in the discovery of insulin and vinblastine
    James R Wright
    Department of Pathology, IWK Health Centre and Dalhousie University, Halifax, Nova Scotia, Canada
    CMAJ 167:1391-6. 2002
  2. ncbi request reprint Why cancer patients enter randomized clinical trials: exploring the factors that influence their decision
    James R Wright
    Juravinski Cancer Centre, 699 Concession St, Hamilton, Ontario L8V 5C2
    J Clin Oncol 22:4312-8. 2004
  3. ncbi request reprint Factors that influence the recruitment of patients to Phase III studies in oncology: the perspective of the clinical research associate
    James R Wright
    Hamilton Regional Cancer Centre, Cancer Care Ontario, Hamilton, Ontario, Canada
    Cancer 95:1584-91. 2002
  4. ncbi request reprint Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia
    James R Wright
    Juravinski Cancer Center at Hamilton Health Sciences, Hamilton, Ontario, Canada
    J Clin Oncol 25:1027-32. 2007
  5. ncbi request reprint Digital necrosis associated with squamous cell carcinoma of the tonsil
    Jim R Wright
    Department of Radiation Oncology, Hamilton Regional Cancer Centre, Cancer Care Ontario, 699 Concession St, Hamilton, Ontario, Canada L8V 5C2
    Head Neck 24:1019-21. 2002
  6. ncbi request reprint Estimating per patient funding for cancer clinical trials: an Ontario based survey
    James R Wright
    Juravinski Cancer Center, Hamilton Health Sciences, 699 Concession St, Hamilton, Ontario, Canada, L8V 5C2
    Contemp Clin Trials 26:421-9. 2005
  7. ncbi request reprint Radiation induced mucositis: co-ordinating a research agenda
    J R Wright
    Department of Radiation Oncology, Hamilton Regional Cancer Center, Cancer Care Ontario, Hamilton, Ontario, Canada
    Clin Oncol (R Coll Radiol) 15:473-7. 2003
  8. ncbi request reprint Pilot study of the quality initiative in rectal cancer strategy
    Marko I Simunovic
    Department of Surgery, McMaster University, Hamilton, Ontario, Canada
    Dis Colon Rectum 47:1594-8. 2004
  9. ncbi request reprint Phase III Trial of an emulsion containing trolamine for the prevention of radiation dermatitis in patients with advanced squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Trial 99-13
    Elizabeth A Elliott
    Juravinski Cancer Centre at Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada
    J Clin Oncol 24:2092-7. 2006
  10. ncbi request reprint Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors
    Edward J Mills
    Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Canada
    Lancet Oncol 7:141-8. 2006

Collaborators

Detail Information

Publications19

  1. pmc Almost famous: E. Clark Noble, the common thread in the discovery of insulin and vinblastine
    James R Wright
    Department of Pathology, IWK Health Centre and Dalhousie University, Halifax, Nova Scotia, Canada
    CMAJ 167:1391-6. 2002
    ..Although one might expect that a physician involved in 2 of Canada's most important medical discoveries during the 20th century must be famous, such was not Clark Noble's fate. He died without so much as an obituary in CMAJ...
  2. ncbi request reprint Why cancer patients enter randomized clinical trials: exploring the factors that influence their decision
    James R Wright
    Juravinski Cancer Centre, 699 Concession St, Hamilton, Ontario L8V 5C2
    J Clin Oncol 22:4312-8. 2004
    ..The present study was undertaken to identify the independent predictors of a cancer patient's decision to enter a randomized clinical trial...
  3. ncbi request reprint Factors that influence the recruitment of patients to Phase III studies in oncology: the perspective of the clinical research associate
    James R Wright
    Hamilton Regional Cancer Centre, Cancer Care Ontario, Hamilton, Ontario, Canada
    Cancer 95:1584-91. 2002
    ..The current study was initiated to explore the factors that influence the decision of patients with cancer regarding clinical trial entry, specifically from the perspective of the CRA...
  4. ncbi request reprint Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia
    James R Wright
    Juravinski Cancer Center at Hamilton Health Sciences, Hamilton, Ontario, Canada
    J Clin Oncol 25:1027-32. 2007
    ..We designed a trial to investigate the effects of epoetin alfa therapy on the QOL of anemic patients with advanced non-small-cell carcinoma of the lung (NSCLC)...
  5. ncbi request reprint Digital necrosis associated with squamous cell carcinoma of the tonsil
    Jim R Wright
    Department of Radiation Oncology, Hamilton Regional Cancer Centre, Cancer Care Ontario, 699 Concession St, Hamilton, Ontario, Canada L8V 5C2
    Head Neck 24:1019-21. 2002
    ..Digital necrosis is an uncommon paraneoplastic syndrome. Fewer than 50 cases have been sporadically reported through the literature over the last 30 years...
  6. ncbi request reprint Estimating per patient funding for cancer clinical trials: an Ontario based survey
    James R Wright
    Juravinski Cancer Center, Hamilton Health Sciences, 699 Concession St, Hamilton, Ontario, Canada, L8V 5C2
    Contemp Clin Trials 26:421-9. 2005
    ..These issues are likely not unique to oncology...
  7. ncbi request reprint Radiation induced mucositis: co-ordinating a research agenda
    J R Wright
    Department of Radiation Oncology, Hamilton Regional Cancer Center, Cancer Care Ontario, Hamilton, Ontario, Canada
    Clin Oncol (R Coll Radiol) 15:473-7. 2003
    ..Any additional information needed before the launch of any potential trial was also requested. In this paper, we will review and summarise the outcomes from the radiation-induced mucositis sessions...
  8. ncbi request reprint Pilot study of the quality initiative in rectal cancer strategy
    Marko I Simunovic
    Department of Surgery, McMaster University, Hamilton, Ontario, Canada
    Dis Colon Rectum 47:1594-8. 2004
    ..We developed the surgeon-directed, multipronged Quality Initiative in Rectal Cancer strategy to encourage surgeons to use total mesorectal excision techniques...
  9. ncbi request reprint Phase III Trial of an emulsion containing trolamine for the prevention of radiation dermatitis in patients with advanced squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Trial 99-13
    Elizabeth A Elliott
    Juravinski Cancer Centre at Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada
    J Clin Oncol 24:2092-7. 2006
    ..This multicentered phase III trial was designed to compare an emulsion containing trolamine against the usual supportive care within each participating institution for patients with head and neck cancer undergoing radiation therapy...
  10. ncbi request reprint Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors
    Edward J Mills
    Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Canada
    Lancet Oncol 7:141-8. 2006
    ..Enrolling participants onto clinical trials of cancer presents an important challenge. We aimed to identify the concerns of patients with cancer about, and the barriers to, participation in clinical trials...
  11. ncbi request reprint The importance of reporting patient recruitment details in phase III trials
    James R Wright
    Juravinski Cancer Centre at Hamilton Health Sciences, and Department of Medicine, McMaster University, Hamilton, ON, Canada
    J Clin Oncol 24:843-5. 2006
  12. ncbi request reprint From ugly fish to conquer death: J J R Macleod's fish insulin research, 1922-24
    James R Wright
    Department of Pathology, IWK Health Centre and Dalhousie University, Halifax, Nova Scotia, Canada
    Lancet 359:1238-42. 2002
    ..As a result of this breakthrough, the scales began to tip heavily in favour of livestock insulin. Nevertheless, research on commercial production of fish insulin continued for another 18 months but was finally abandoned...
  13. ncbi request reprint Public consultation on xenotransplantation
    James R Wright
    Departments of Pathology, Surgery, and Biomedical Engineering, Dalhousie University Faculty of Medicine and IWK Health Centre, 5850 University Avenue, Halifax, Nova Scotia B3H 1V7, Canada
    Transplantation 78:1112-3. 2004
    ..I offer an alternative analysis of the data collected during the consultation, which results in different conclusions...
  14. ncbi request reprint Researching the cost of research
    James R Wright
    J Clin Oncol 21:4081-2. 2003
  15. ncbi request reprint Commentary on the Canadian public consultation on xenotransplantation
    James R Wright
    Xenotransplantation 10:475-6. 2003
  16. ncbi request reprint Association between Breus' mole and partial hydatidiform mole: chance or can hydropic villi precipitate placental massive subchorionic thrombosis?
    Dae Tong Kim
    Department of Pathology, IWK Grace Health Centre, Halifax, Nova Scotia, Canada
    Pediatr Pathol Mol Med 21:451-9. 2002
    ..Thus, we suggest that obstruction of maternal venous return by hydropic villi may have played a contributory role in some of these other reported cases...
  17. pmc Alternative interpretations of the same data: flaws in the process of consulting the Canadian public about xenotransplantation issues
    James R Wright
    Department of Pathology, IWK Health Centre, Dalhousie University, Halifax, NS
    CMAJ 167:40-2. 2002
  18. doi request reprint Association of phosphorylated epidermal growth factor receptor with survival in patients with locally advanced non-small cell lung cancer treated with radiotherapy
    Theodoros Tsakiridis
    Department of Oncology, McMaster University, McMaster University, Hamilton, Ontario, Canada
    J Thorac Oncol 3:716-22. 2008
    ..The epidermal growth factor receptor (EGFR) and its downstream effector kinases are thought to have important roles in lung cancer cell proliferation and response to treatment...